TIMP-2 disrupts FGF-2-induced downstream signaling pathways

Microvascular Research

Volumn 76, Issue 3, 2008, Pages 145-151

  Seo, Dong Wan ^a   Kim, Soo Hyeon ^a   Eom, Seok Hyun ^a   Yoon, Hyun Jae ^a   Cho, Young Rak ^a   Kim, Pyeung Hyeun ^a   Kim, Yong Kee ^b   Han, Jeung Whan ^c   Diaz, Tere ^d   Wei, Bei yang ^d   Stetler Stevenson, William G ^d  

^a Kangwon National University   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; FGF 2; Integrin 3 1; Shp 1; TIMP 2

Indexed keywords

ALPHA3 INTEGRIN; BLOCKING ANTIBODY; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ORTHOVANADIC ACID; PROTEIN TYROSINE PHOSPHATASE SHP 1; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VERY LATE ACTIVATION ANTIGEN 3;

ARTICLE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTEGRIN ALPHA3BETA1; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 53849109150     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2008.07.003     Document Type: Article

References (32)

1. Baker A.H., Edwards D.R., and Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115 (2002) 3719-3727
2. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
3. Chang H., Lee J., Poo H., Noda M., Diaz T., Wei B., Stetler-Stevenson W.G., and Oh J. TIMP-2 promotes cell spreading and adhesion via upregulation of Rap1 signaling. Biochem. Biophys. Res. Commun. 345 (2006) 1201-1206
4. Corcoran M.L., and Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J. Biol. Chem. 270 (1995) 13453-13459
5. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer-trials and tribulations. Science 295 (2002) 2387-2392
6. Dhillon A.S., Pollock C., Steen H., Shaw P.E., Mischak H., and Kolch W. Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol. Cell. Biol. 22 (2002) 3237-3246
7. Fernandez C.A., Butterfield C., Jackson G., and Moses M.A. Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): LOOP 6 is a novel angiogenesis inhibitor. J. Biol. Chem. 278 (2003) 40989-40995
8. Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 (2005) 967-974
9. FFrench-Constant C., and Colognato H. Integrins: versatile integrators of extracellular signals. Trends Cell Biol. 14 (2004) 678-686
10. Folkman J. Angiogenesis. Annu. Rev. Med. 57 (2006) 1-18
11. Guedez L., Stetler-Stevenson W.G., Wolff L., Wang J., Fukushima P., Mansoor A., and Stetler-Stevenson M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Invest. 102 (1998) 2002-2010
12. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
13. Hoegy S.E., Oh H.-R., Corcoran M.L., and Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J. Biol. Chem. 276 (2001) 3203-3214
14. Jung K.K., Liu X.W., Chirco R., Fridman R., and Kim H.R. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J. 25 (2006) 3934-3942
15. Kouhara H., Hadari Y.R., Spivak-Kroizman T., Schilling J., Bar-Sagi D., Lax I., and Schlessinger J. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89 (1997) 693-702
16. Nyberg P., Xie L., and Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res. 65 (2005) 3967-3979
17. Oh J., Seo D.-W., Diaz T., Wei B., Ward Y., Ray J.M., Morioka Y., Shi S., Kitayama H., Takahashi C., Noda M., and Stetler-Stevenson W.G. Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Res. 64 (2004) 9062-9069
18. Ostman A., Hellberg C., and Bohmer F.D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 6 (2006) 307-320
19. Perez-Martinez L., and Jaworski D.M. Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J. Neurosci. 25 (2005) 4917-4929
20. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., Baker A., and Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9 (2003) 407-415
21. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70 (2001) 281-312
22. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
23. Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306 (2004) 1506-1507
24. Schlessinger J., and Lemmon M.A. SH2 and PTB domains in tyrosine kinase signaling. Sci. STKE 2003 (2003) re12
25. Seo D.-W., Li H., Guedez L., Wingfield P.T., Diaz T., Salloum R., Wei B.-y., and Stetler-Stevenson W.G. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 114 (2003) 171-180
26. Seo D.-W., Li H., Qu C.-K., Oh J., Kim Y.-S., Diaz T., Wei B., Han J.-W., and Stetler-Stevenson W.G. Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial Cells. J. Biol. Chem. 281 (2006) 3711-3721
27. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17 (2001) 463-516
28. Stetler-Stevenson W.G. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 103 (1999) 1237-1241
29. Stetler-Stevenson W.G., and Seo D.-W. TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol. Med. 11 (2005) 97-103
30. Stetler-Stevenson W.G. The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. Cancer Metastasis Rev. 27 (2008) 57-66
31. Stupack D.G., Cheresh D.A., and Gerald P.S. Integrins and angiogenesis. In: Schatten G.P. (Ed). Current Topics in Developmental Biology Vol. 64 (2004), Academic Press 207-238
32. Wingfield P.T., Sax J.K., Stahl S.J., Kaufman J., Palmer I., Chung V., Corcoran M.L., Kleiner D.E., and Stetler-Stevenson W.G. Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions. J. Biol. Chem. 274 (1999) 21362-21368